Biopharma Mid Morning Pulse - 08/01/22
(Posted 10:20am CST) $XBI $80.99 | -0.17% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
top of page
BPIQ Blog
Aug 1, 20221 min read
Free Biopharma Mid Morning Pulse - 08/01/22
(Posted 10:20am CST) $XBI $80.99 | -0.17% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 5, 20222 min read
Biopharma Daily Stock Updates - 07/05/22
$XBI $80.99 | +5.81% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #LXRX +41.8%...
Jul 5, 20222 min read
Free Biopharma Daily Stock Updates - 07/05/22
$XBI $80.99 | +5.81% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #LXRX +41.8%...
Jun 29, 20222 min read
Biopharma Daily Stock Updates - 06/29/22
$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...
Jun 29, 20222 min read
Free Biopharma Daily Stock Updates - 06/29/22
$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...
Jun 10, 20223 min read
Biopharma Daily Stock Updates - 06/10/22
$XBI $67.03 | -4.60% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #GRTS -0.4% Gritstone Announces...
Jun 10, 20223 min read
Free Biopharma Daily Stock Updates - 06/10/22
$XBI $67.03 | -4.60% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #GRTS -0.4% Gritstone Announces...
Jun 22, 20214 min read
COVID-19 Therapeutic Stocks to Watch (June 2021)
Summary Over 40 Smid-Cap companies currently have active trials involving COVID therapeutics (this includes small molecules and...
Apr 10, 20211 min read
AACR 2021 Initial Readouts
American Association for Cancer Research (AACR) presentations are happening this weekend and into early next week (see image below for a...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page